Skip to Content

Notice

Importer of Controlled Substances Application: Restek Corporation

This document has a comment period that ends in 21 days. (06/15/2020) Submit a formal comment

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 29486

ACTION:

Notice of application.

DATES:

Registered bulk manufacturer of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 15, 2020. Such persons may also file a written request for a hearing on the application on or before June 15, 2020.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.34(a), this is notice that on March 23, 2020, Restek Corporation, 110 Benner Circle, Bellefonte, Pennsylvania 16823, applied to be registered as an importer of the following basic class(es) of controlled substances:

Controlled substanceDrug codeSchedule
Tetrahydrocannabinols7370I

The company plans to import the listed controlled substance in bulk for manufacture of analytical reference material which, in its final form, is an exempted product.

Start Signature

William T. McDermott,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2020-10465 Filed 5-14-20; 8:45 am]

BILLING CODE 4410-09-P